222 related articles for article (PubMed ID: 19248123)
1. Scleroderma prevalence: demographic variations in a population-based sample.
Bernatsky S; Joseph L; Pineau CA; Belisle P; Hudson M; Clarke AE
Arthritis Rheum; 2009 Mar; 61(3):400-4. PubMed ID: 19248123
[TBL] [Abstract][Full Text] [Related]
2. Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences.
Bernatsky S; Joseph L; Pineau CA; Bélisle P; Boivin JF; Banerjee D; Clarke AE
Ann Rheum Dis; 2009 Jul; 68(7):1192-6. PubMed ID: 18713785
[TBL] [Abstract][Full Text] [Related]
3. Polymyalgia rheumatica prevalence in a population-based sample.
Bernatsky S; Joseph L; Pineau CA; Belisle P; Lix L; Banerjee D; Clarke AE
Arthritis Rheum; 2009 Sep; 61(9):1264-7. PubMed ID: 19714587
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada.
Barnabe C; Joseph L; Belisle P; Labrecque J; Edworthy S; Barr SG; Fritzler M; Svenson LW; Hemmelgarn B; Bernatsky S
Arthritis Care Res (Hoboken); 2012 Jan; 64(1):138-43. PubMed ID: 21972194
[TBL] [Abstract][Full Text] [Related]
5. A population-based assessment of systemic lupus erythematosus incidence and prevalence--results and implications of using administrative data for epidemiological studies.
Bernatsky S; Joseph L; Pineau CA; Tamblyn R; Feldman DE; Clarke AE
Rheumatology (Oxford); 2007 Dec; 46(12):1814-8. PubMed ID: 18032538
[TBL] [Abstract][Full Text] [Related]
6. Systemic autoimmune rheumatic disease prevalence in Canada: updated analyses across 7 provinces.
Broten L; Aviña-Zubieta JA; Lacaille D; Joseph L; Hanly JG; Lix L; O'Donnell S; Barnabe C; Fortin PR; Hudson M; Jean S; Peschken C; Edworthy SM; Svenson L; Pineau CA; Clarke AE; Smith M; Bélisle P; Badley EM; Bergeron L; Bernatsky S
J Rheumatol; 2014 Apr; 41(4):673-9. PubMed ID: 24584928
[TBL] [Abstract][Full Text] [Related]
7. Increased prevalence of scleroderma in southwestern Ontario: a cluster analysis.
Thompson AE; Pope JE
J Rheumatol; 2002 Sep; 29(9):1867-73. PubMed ID: 12233880
[TBL] [Abstract][Full Text] [Related]
8. Prevalence of systemic sclerosis in a French multi-ethnic county.
Le Guern V; Mahr A; Mouthon L; Jeanneret D; Carzon M; Guillevin L
Rheumatology (Oxford); 2004 Sep; 43(9):1129-37. PubMed ID: 15213329
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of autoimmune inflammatory myopathy in the first nations population of Alberta, Canada.
Barnabe C; Joseph L; Bélisle P; Labrecque J; Barr SG; Fritzler MJ; Svenson LW; Peschken CA; Hemmelgarn B; Bernatsky S
Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1715-9. PubMed ID: 22623451
[TBL] [Abstract][Full Text] [Related]
10. A study of the prevalence of systemic sclerosis in northeast England.
Allcock RJ; Forrest I; Corris PA; Crook PR; Griffiths ID
Rheumatology (Oxford); 2004 May; 43(5):596-602. PubMed ID: 14872101
[TBL] [Abstract][Full Text] [Related]
11. Epidemiology of systemic sclerosis in northwest Greece 1981 to 2002.
Alamanos Y; Tsifetaki N; Voulgari PV; Siozos C; Tsamandouraki K; Alexiou GA; Drosos AA
Semin Arthritis Rheum; 2005 Apr; 34(5):714-20. PubMed ID: 15846586
[TBL] [Abstract][Full Text] [Related]
12. Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria.
Andréasson K; Saxne T; Bergknut C; Hesselstrand R; Englund M
Ann Rheum Dis; 2014 Oct; 73(10):1788-92. PubMed ID: 23897770
[TBL] [Abstract][Full Text] [Related]
13. Bayesian modelling of imperfect ascertainment methods in cancer studies.
Bernatsky S; Joseph L; Bélisle P; Boivin JF; Rajan R; Moore A; Clarke A
Stat Med; 2005 Aug; 24(15):2365-79. PubMed ID: 15977290
[TBL] [Abstract][Full Text] [Related]
14. Rheumatoid arthritis prevalence in Quebec.
Bernatsky S; Dekis A; Hudson M; Pineau CA; Boire G; Fortin PR; Bessette L; Jean S; Chetaille AL; Belisle P; Bergeron L; Feldman DE; Joseph L
BMC Res Notes; 2014 Dec; 7():937. PubMed ID: 25527187
[TBL] [Abstract][Full Text] [Related]
15. Systemic sclerosis and its pulmonary complications in The Netherlands: an epidemiological study.
Vonk MC; Broers B; Heijdra YF; Ton E; Snijder R; van Dijk AP; van Laar JM; Bootsma H; van Hal PT; van den Hoogen FH; van Daele PL
Ann Rheum Dis; 2009 Jun; 68(6):961-5. PubMed ID: 18511546
[TBL] [Abstract][Full Text] [Related]
16. Relationship between occupational risk factors and severity markers of systemic sclerosis.
Magnant J; de Monte M; Guilmot JL; Lasfargues G; Diot P; Asquier E; Degenne D; Boissinot E; Diot E
J Rheumatol; 2005 Sep; 32(9):1713-8. PubMed ID: 16142866
[TBL] [Abstract][Full Text] [Related]
17. Estimating the prevalence of systemic sclerosis in the Lorraine region, France, by the capture-recapture method.
El Adssi H; Cirstea D; Virion JM; Guillemin F; de Korwin JD
Semin Arthritis Rheum; 2013 Apr; 42(5):530-8. PubMed ID: 23290691
[TBL] [Abstract][Full Text] [Related]
18. Geoepidemiology of systemic sclerosis.
Ranque B; Mouthon L
Autoimmun Rev; 2010 Mar; 9(5):A311-8. PubMed ID: 19906362
[TBL] [Abstract][Full Text] [Related]
19. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products.
Maître A; Hours M; Bonneterre V; Arnaud J; Arslan MT; Carpentier P; Bergeret A; de Gaudemaris R
J Rheumatol; 2004 Dec; 31(12):2395-401. PubMed ID: 15570640
[TBL] [Abstract][Full Text] [Related]
20. Stroke surveillance in Manitoba, Canada: estimates from administrative databases.
Moore DF; Lix LM; Yogendran MS; Martens P; Tamayo A
Chronic Dis Can; 2008; 29(1):22-30. PubMed ID: 19036220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
